StemCell Institute Inc. (TYO:7096)

Japan · Delayed Price · Currency is JPY

746.00

-2.00 (-0.27%)

Oct 9, 2026, 3:30 PM JST

Market Cap	7.51B -21.4%
Revenue (ttm)	2.81B +4.9%
Net Income	155.00M -59.7%
EPS	15.35 -59.2%
Shares Out	10.07M
PE Ratio	48.60
Forward PE	51.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,100
Open	748.00
Previous Close	748.00
Day's Range	746.00 - 757.00
52-Week Range	627.00 - 976.00
Beta	0.64
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is involved in Cell management and transportation services; extraction, purification, processing, storage, testing, and sale of components derived from biological tissues; research, and development, and dissemination of cell-based therapies. Its also offers the manufacturing, wholesale distribution, and sale of pharmaceuticals and medical devices. In addition, the company operates and manages medical facilities, conducts real estate leasing and property mana... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 117

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7096

Full Company Profile

Financial Performance

In fiscal year 2026, StemCell Institute's revenue was 2.81 billion, an increase of 4.93% compared to the previous year's 2.68 billion. Earnings were 155.00 million, a decrease of -59.74%.

Financial Statements